NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
1-Year Return 35.61%
This Quarter Return
+4.35%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
10 Year Return
AUM
$117M
AUM Growth
+$850K
Cap. Flow
+$5.36M
Cap. Flow %
4.58%
Top 10 Hldgs %
62.08%
Holding
41
New
3
Increased
8
Reduced
2
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TRDA icon
26
Entrada Therapeutics
TRDA
$199M
$849K 0.73%
49,082
RVMD icon
27
Revolution Medicines
RVMD
$7.22B
$842K 0.72%
19,253
+11,953
+164% +$523K
CLYM
28
Climb Bio, Inc. Common Stock
CLYM
$159M
$835K 0.71%
463,654
RANI icon
29
Rani Therapeutics
RANI
$21.4M
$676K 0.58%
493,584
BOLT icon
30
Bolt Biotherapeutics
BOLT
$9.41M
$624K 0.53%
58,348
BSLK
31
Bolt Projects Holdings, Inc. Common Stock
BSLK
$12.1M
$391K 0.33%
40,598
ARGX icon
32
argenx
ARGX
$44.9B
$264K 0.23%
430
DBVT
33
DBV Technologies
DBVT
$254M
$115K 0.1%
37,095
ALXO icon
34
ALX Oncology
ALXO
$56.2M
$70.1K 0.06%
41,950
AFMD
35
DELISTED
Affimed
AFMD
$44.3K 0.04%
37,247
JBIO
36
Jade Biosciences, Inc. Common Stock
JBIO
$246M
-1,370
Closed -$100K
BMRN icon
37
BioMarin Pharmaceuticals
BMRN
$10.9B
-10,815
Closed -$760K
RARE icon
38
Ultragenyx Pharmaceutical
RARE
$3.02B
-3,820
Closed -$212K
SWTX
39
DELISTED
SpringWorks Therapeutics
SWTX
-7,450
Closed -$239K
EXAI
40
DELISTED
Exscientia Plc American Depositary Shares
EXAI
-859,892
Closed -$4.2M
LBPH
41
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
-160,570
Closed -$5.35M